GEMFIBROZIL Side Effects

7010093-3 | Dizziness, Muscle Spasms, Pain In Extremity, Vision Blurred
on May 06, 2010 Male patient from UNITED STATES , 71 years of age, weighting 172.0 lb, was diagnosed with cardiac disorder, hypertriglyceridaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), muscle spasms, pain in extremity, vision blurred. Gemfibrozil dosage: 600 Mg, 2x/day, Oral. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), MEVACOR (View Mevacor Review and Mevacor Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6981186-1 | Blood Glucose Decreased, Overdose, Pruritus, Somnolence, Urticaria
Patient was taking Gemfibrozil (View Usage). Patient had the following side effects: blood glucose decreased, overdose, pruritus, somnolence, urticaria on Aug 10, 2010 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 220.0 lb, was diagnosed with blood triglycerides increased, diabetes mellitus, hypertension and. Gemfibrozil dosage: 160 Mg, 1x/day. During the same period patient was treated with TRICOR (200 Mg, 1x/day) (View Tricor Review and Tricor Label ), EXENATIDE (Unk) (View Exenatide Review and Exenatide Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ).

6914923-2 | Mental Status Changes, Rhabdomyolysis
Adverse event was reported on Aug 04, 2010 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 40 Mg Every Day Po) . Location: UNITED STATES , 65 years of age, After Gemfibrozil was administered, patient had the following side effects: mental status changes, rhabdomyolysis. Patient was hospitalized.

6914707-5 | Rhabdomyolysis
on Aug 04, 2010 Male patient from UNITED STATES , 65 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus, hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with SIMVASTATIN (80 Mg At Bedtime Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


6815303-0 | Diarrhoea Haemorrhagic, Myalgia, Tinnitus
on Jul 01, 2010 Male patient from UNITED STATES , weighting 210.0 lb, was diagnosed with blood triglycerides increased and was treated with Gemfibrozil (View Usage). Patient had the following side effects: diarrhoea haemorrhagic, myalgia, tinnitus (What is tinnitus?). Gemfibrozil dosage: 600 Mg 2 X Day Po.

6710285-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Calcium Decreased, Blood Sodium Decreased, Haemodialysis, Hepatic Function Abnormal, Plasmapheresis
Patient was taking Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood calcium decreased, blood sodium decreased, haemodialysis, hepatic function abnormal, plasmapheresis on Apr 17, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, . Gemfibrozil dosage: 600 Mg; Bid. During the same period patient was treated with SIMVASTATIN (80 Mg; Qd) (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ). Patient was hospitalized.

6644029-1 | Arthralgia, Chest Pain, Depression, Dizziness, Dyspepsia, Feeling Abnormal, Headache, Hunger
Adverse event was reported on Mar 19, 2010 by a Female patient taking Gemfibrozil (View Usage) (Dosage: 600mg Twice Daily) was diagnosed with blood cholesterol, blood triglycerides increased and. Location: UNITED STATES , 68 years of age, weighting 168.0 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, chest pain (What is chest pain?), depression (What is depression?), dizziness (What is dizziness?), dyspepsia, feeling abnormal, headache (What is headache?), hunger.

6620897-4 | Abdominal Discomfort, Abdominal Pain, Nausea, Vomiting Projectile
on Mar 08, 2010 Female patient from UNITED STATES , 58 years of age, weighting 178.0 lb, was diagnosed with blood cholesterol increased and was treated with Gemfibrozil (View Usage). Patient had the following side effects: abdominal discomfort, abdominal pain (What is abdominal pain?), nausea (What is nausea?), vomiting projectile. Gemfibrozil dosage: 2 Pills Per Day 30 Mins Before Mea Po.

6620661-6 | Metaplasia
on Feb 26, 2010 Female patient from UNITED STATES , weighting 130.1 lb, was diagnosed with blood triglycerides increased, hypersensitivity, anaemia and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: metaplasia. Gemfibrozil dosage: 600 Mg, Unk. During the same period patient was treated with ALLEGRA (Unk) (View Allegra Review and Allegra Label ), IRON (Unk) (View Iron Review and Iron Label ).

6608628-5 | Pain In Extremity
Patient was taking Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: pain in extremity on Feb 26, 2010 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 248.0 lb, . Gemfibrozil dosage: 1200mg Po. During the same period patient was treated with SIMVASTATIN (40mg Po) (View Simvastatin Review and Simvastatin Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

6600817-9 | Myalgia, Vision Blurred
Adverse event was reported on Feb 23, 2010 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 2 Per Day Po) was diagnosed with blood triglycerides, blood cholesterol and. Location: UNITED STATES , 47 years of age, weighting 270.0 lb, Patient had the following side effects: myalgia, vision blurred. During the same period patient was treated with SIMVASTATIN (1 Half At Bedtime Po) (View Simvastatin Review and Simvastatin Label ).

6595321-0 | Arthralgia, Constipation, Diarrhoea, Gastrointestinal Pain, Myalgia, Nausea
on Feb 19, 2010 Female patient from UNITED STATES , 71 years of age, weighting 132.0 lb, was diagnosed with blood cholesterol increased and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: arthralgia, constipation (What is constipation?), diarrhoea, gastrointestinal pain, myalgia, nausea (What is nausea?). Gemfibrozil dosage: 1 Twice Daily Po.

6582650-X | Renal Failure, Rhabdomyolysis
on Feb 12, 2010 Male patient from UNITED STATES , 72 years of age, weighting 173.3 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, rhabdomyolysis. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with ROSUVASTATIN (20 Mg At Bedtime Po) (View Rosuvastatin Review and Rosuvastatin Label ).

6578834-7 | Completed Suicide, Poisoning
Patient was taking Gemfibrozil (View Usage). Patient had the following side effects: completed suicide, poisoning (What is poisoning?) on Jan 18, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Gemfibrozil dosage: Df Oral. During the same period patient was treated with METOPROLOL TARTRATE (Df Oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (Df Oral) (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ), ETHANOL (Oral) (View Ethanol Review and Ethanol Label ).

6538113-0 | Completed Suicide
Adverse event was reported on Jan 04, 2010 by a Female patient taking Gemfibrozil (View Usage) (Dosage: ) . Location: UNITED STATES , 66 years of age, After Gemfibrozil was administered, patient had the following side effects: completed suicide. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), PROPOXYPHENE HCL AND ACETAMINOPHEN (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ).

6535029-0 | Decreased Activity, Decreased Appetite, Dizziness Postural, Dysstasia, Exercise Tolerance Decreased, Hypophagia, Malaise, Nausea, Oedema
on Jan 11, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: decreased activity, decreased appetite, dizziness postural, dysstasia, exercise tolerance decreased, hypophagia, malaise, nausea (What is nausea?), oedema. Gemfibrozil dosage: 1200 Mg Bid Po. Patient was hospitalized.

6504046-9 | Abasia, Arthralgia, Blood Creatine Phosphokinase Increased
on Dec 16, 2009 Female patient from UNITED STATES , 84 years of age, weighting 121.3 lb, was diagnosed with hyperlipidaemia, diabetes mellitus and was treated with Gemfibrozil (View Usage). Patient had the following side effects: abasia, arthralgia, blood creatine phosphokinase increased. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with SIMVASTATIN (40 Mg Pm Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6502335-5 | Renal Failure Acute
Patient was taking Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: renal failure acute on Dec 03, 2009 from SPAIN Additional patient health information: Female patient , 67 years of age, was diagnosed with hyperlipidaemia and. Gemfibrozil dosage: Oral.

6502334-3 | Renal Failure Acute
Adverse event was reported on Dec 03, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: Oral) was diagnosed with hyperlipidaemia and. Location: SPAIN , 44 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute.

6483158-2 | Blood Creatinine Increased, Liver Function Test Abnormal, Rhabdomyolysis
on Dec 08, 2009 Male patient from UNITED STATES , 73 years of age, weighting 162.0 lb, was diagnosed with hyperlipidaemia, pain (What is pain?) and was treated with Gemfibrozil (View Usage). Patient had the following side effects: blood creatinine increased, liver function test abnormal, rhabdomyolysis. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with SIMVASTATIN (80 Mg Hs Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6467024-4 | Renal Failure
on Nov 24, 2009 Male patient from SPAIN , 44 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: renal failure. Gemfibrozil dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6467023-2 | Renal Failure
Patient was taking Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure on Nov 24, 2009 from SPAIN Additional patient health information: Female patient , 67 years of age, was diagnosed with hyperlipidaemia and. Gemfibrozil dosage: .

6466569-0 | Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Muscular Weakness, Myalgia
Adverse event was reported on Dec 01, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 600mg Bid Po) was diagnosed with hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 71 years of age, weighting 219.0 lb, Patient had the following side effects: blood creatine phosphokinase increased, blood creatinine increased, muscular weakness, myalgia. During the same period patient was treated with MULTAQ (400mg Bid Po) (View Multaq Review and Multaq Label ).

6445715-9 | Alopecia
on Nov 18, 2009 Female patient from UNITED STATES , 55 years of age, weighting 200.0 lb, was diagnosed with blood triglycerides increased and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: alopecia. Gemfibrozil dosage: 1 600mg Tab Twice A Day.

6441756-6 | Blood Creatine Phosphokinase Increased
on Nov 13, 2009 Male patient from UNITED STATES , 50 years of age, weighting 264.0 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Gemfibrozil dosage: 600 Mg At Bedtime Po.

6438169-X | Renal Failure
Patient was taking Gemfibrozil (View Usage). Patient had the following side effects: renal failure on Oct 28, 2009 from SPAIN Additional patient health information: Male patient , 44 years of age, . Gemfibrozil dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6438147-0 | Renal Failure
Adverse event was reported on Oct 28, 2009 by a Female patient taking Gemfibrozil (View Usage) (Dosage: ) . Location: SPAIN , 67 years of age, After Gemfibrozil was administered, patient had the following side effects: renal failure.

6431006-9 | Abdominal Discomfort
on Nov 05, 2009 Male patient from UNITED STATES , 63 years of age, weighting 180.8 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort. Gemfibrozil dosage: 600 Mg Bid Po.

6428639-2 | Myalgia
on Nov 04, 2009 Male patient from UNITED STATES , 79 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient had the following side effects: myalgia. Gemfibrozil dosage: 1 Tab Bid Po. During the same period patient was treated with SIMVASTATIN (80 Mg Pm Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6427860-7 | Pancreatitis
Patient was taking Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: pancreatitis on Nov 04, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with hyperlipidaemia and. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with LOVASTATIN (20 Mg Every Day Po) (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

6425914-2 | Arthralgia, Myalgia, Swelling
Adverse event was reported on Nov 03, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 1 Tab Bid Po) . Location: UNITED STATES , 50 years of age, weighting 213.8 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, myalgia, swelling.

6425636-8 | Renal Impairment
on Oct 20, 2009 Male patient from SPAIN , 44 years of age, was treated with Gemfibrozil (View Usage). Patient had the following side effects: renal impairment. Gemfibrozil dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6425613-7 | Renal Impairment
on Oct 20, 2009 Female patient from SPAIN , 67 years of age, was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: renal impairment. Gemfibrozil dosage: .

6424714-7 | Blood Creatine Phosphokinase Increased, Blood Triglycerides Increased, Myalgia, Renal Failure Acute
Patient was taking Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood triglycerides increased, myalgia, renal failure acute on Oct 30, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with hyperlipidaemia and. Gemfibrozil dosage: 600 Mg Bid Po. During the same period patient was treated with SIMVASTATIN (10 Mg Every Day Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6423851-0 | Dysgeusia, Product Quality Issue, Product Substitution Issue
Adverse event was reported on Oct 30, 2009 by a Female patient taking Gemfibrozil (View Usage) (Dosage: 600 Mg Bid Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: dysgeusia, product quality issue, product substitution issue.

6413048-2 | Confusional State, Suicidal Ideation
on Oct 23, 2009 Female patient from UNITED STATES , 40 years of age, weighting 165.0 lb, was diagnosed with blood triglycerides increased and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: confusional state, suicidal ideation. Gemfibrozil dosage: 600 Mg. 2 X Day.

6360585-5 | Adverse Reaction, Blood Creatine Phosphokinase Decreased, Blood Creatine Phosphokinase Increased, Delirium, Haemoptysis, Hepatic Failure, Lung Infiltration
on Sep 02, 2009 Male patient from UNITED STATES , 79 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: adverse reaction, blood creatine phosphokinase decreased, blood creatine phosphokinase increased, delirium, haemoptysis, hepatic failure, lung infiltration. Gemfibrozil dosage: 600 Mg;bid;po. During the same period patient was treated with LOVASTATIN (40 Mg;qd;po) (View Lovastatin Review and Lovastatin Label ), LINEZOLID (600 Mg;q12h;iv) (View Linezolid Review and Linezolid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), IPRATROPIUM (View Ipratropium Review and Ipratropium Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6357813-9 | Blood Albumin Decreased, Renal Failure Acute, Rhabdomyolysis
Patient was taking Gemfibrozil (View Usage). Patient had the following side effects: blood albumin decreased, renal failure acute, rhabdomyolysis on Aug 31, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, . Gemfibrozil dosage: 600 Mg;bid. During the same period patient was treated with SIMVASTATIN (80 Mg;qd) (View Simvastatin Review and Simvastatin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized.

6344632-2 | Blood Creatine Phosphokinase Increased, Haemoptysis, Multi-organ Failure, Pneumonia Staphylococcal, Respiratory Failure, Sepsis
Adverse event was reported on Aug 22, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 600 Mg;bid;po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 79 years of age, After Gemfibrozil was administered, patient had the following side effects: blood creatine phosphokinase increased, haemoptysis, multi-organ failure, pneumonia staphylococcal, respiratory failure, sepsis (What is sepsis?). During the same period patient was treated with LOVASTATIN (40 Mg;qd;po) (View Lovastatin Review and Lovastatin Label ), LINEZOLID (600 Mg; Q12h; Iv) (View Linezolid Review and Linezolid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6340683-2 | Abasia, Dysstasia, Myalgia
on Sep 02, 2009 Female patient from UNITED STATES , 57 years of age, weighting 283.0 lb, was diagnosed with hypercholesterolaemia and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, dysstasia, myalgia. Gemfibrozil dosage: 1 Daily Po.

6321707-5 | Swelling Face, Swollen Tongue
on Aug 21, 2009 Female patient from UNITED STATES , 77 years of age, weighting 135.0 lb, was diagnosed with blood cholesterol, blood triglycerides and was treated with Gemfibrozil (View Usage). Patient had the following side effects: swelling face, swollen tongue. Gemfibrozil dosage: 600 Mg 2 X A Day. Patient was hospitalized.

6313836-7 | Rhabdomyolysis
Patient was taking Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: rhabdomyolysis on Aug 04, 2009 from SPAIN Additional patient health information: Male patient , 37 years of age, was diagnosed with hypertriglyceridaemia and. Gemfibrozil dosage: .

6311763-2 | Rhabdomyolysis
Adverse event was reported on Aug 13, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: 600 Mg Bid Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 47 years of age, weighting 206.0 lb, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. During the same period patient was treated with SIMVASTATIN (40 Mg Pm Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6311762-0 | Rhabdomyolysis
on Aug 13, 2009 Male patient from UNITED STATES , 60 years of age, weighting 170.4 lb, was treated with Gemfibrozil (View Usage). Patient had the following side effects: rhabdomyolysis. Gemfibrozil dosage: 1 Tab Bid Po.

6295249-X | International Normalised Ratio Increased, Myalgia
on Jul 21, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with dyslipidaemia and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: international normalised ratio increased, myalgia. Gemfibrozil dosage: . During the same period patient was treated with WARFARIN SODIUM (Stabilised On 45mg/week For Past 9 Months) (View Warfarin Sodium Review and Warfarin Sodium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (100mg Morning And 200mg Evening) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DYAZIDE (Triamterene 37.5mg/hydrochlorothiazide 25mg/day) (View Dyazide Review and Dyazide Label ), FUROSEMIDE (40mg/day) (View Furosemide Review and Furosemide Label ), DILTIAZEM (300mg/day) (View Diltiazem Review and Diltiazem Label ).

6291589-9 | Rhabdomyolysis
Patient was taking Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Jul 18, 2009 from TURKEY Additional patient health information: Male patient , 40 years of age, . Gemfibrozil dosage: . During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ).

6291588-7 | Renal Failure Acute, Rhabdomyolysis
Adverse event was reported on Jul 18, 2009 by a Male patient taking Gemfibrozil (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 30 years of age, Patient had the following side effects: renal failure acute, rhabdomyolysis. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6291568-1 | Hepatic Enzyme Increased
on Jul 18, 2009 Male patient from UNITED STATES , 43 years of age, weighting 222.7 lb, was diagnosed with hypertriglyceridaemia, malignant melanoma and was treated with Gemfibrozil (View Usage). After Gemfibrozil was administered, patient had the following side effects: hepatic enzyme increased. Gemfibrozil dosage: . During the same period patient was treated with INTERFERON ALFA (Weeks 1, 2, 3, 4, 8, 16, 24, 32, 40, 48 And Then Every 8 Weeks Until Week 104) (View Interferon Alfa Review and Interferon Alfa Label ).

6291530-9 | Hepatitis
on Jul 18, 2009 Female patient from CROATIA (local name: Hrvatska) , 61 years of age, was diagnosed with hyperlipidaemia, malignant melanoma and was treated with Gemfibrozil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Gemfibrozil dosage: . During the same period patient was treated with INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ).

6291244-5 | Abasia, Blood Potassium Increased, Renal Failure, Rhabdomyolysis
Patient was taking Gemfibrozil (View Usage). Patient had the following side effects: abasia, blood potassium increased, renal failure, rhabdomyolysis on Jul 29, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 180.0 lb, was diagnosed with blood cholesterol and. Gemfibrozil dosage: 1 Tablet Twice A Day Po. Patient was hospitalized.